Actively Recruiting
A New Cardiac Rehabilitation Treatment in the Application of Ischemic Heart Disease
Led by Shanghai 10th People's Hospital · Updated on 2024-11-08
100
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
Sponsors
S
Shanghai 10th People's Hospital
Lead Sponsor
S
Shanghai Municipal Science and Technology Commission
Collaborating Sponsor
AI-Summary
What this Trial Is About
Cardiac rehabilitation is an important link in cardiovascular disease. This study mainly explores the effectiveness of new cardiac rehabilitation therapy (early respiratory rehabilitation, phase I rehabilitation, exercise therapy, external counterpulsation, extracorporeal shock wave, etc.) on patients with ischemic heart disease such as coronary heart disease and heart failure, and the compliance of home rehabilitation compared with traditional cardiac rehabilitation therapy (traditional exercise rehabilitation, rehabilitation education, etc.).
CONDITIONS
Official Title
A New Cardiac Rehabilitation Treatment in the Application of Ischemic Heart Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged between 18 and 85 years old
- Female subjects must not be pregnant
- Main admission diagnosis of ischemic heart disease (coronary heart disease, myocardial infarction, ischemic heart failure, etc.)
- Need for cardiac rehabilitation treatment
You will not qualify if you...
- Acute respiratory distress syndrome (ARDS)
- Acute episode of COPD
- Uncontrolled pulmonary infection
- Acute heart failure or acute pulmonary embolism
- Acute myocarditis or pericarditis
- Severe arrhythmia (degree II or III atrioventricular block, atrial flutter, or atrial fibrillation)
- Sternotomy, rib fracture, thoracic deformity, or neurological diseases affecting respiratory muscles
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Cardiology, Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China, 200072
Actively Recruiting
Research Team
L
liujing liu, MD, PhD
CONTACT
Z
zhaoxin zhu, B.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here